Advertisement
Screener

GALECTIN THERAPEUTICS INC. (GALT) Earnings Per Share, Basic and Diluted

2.8 / 5 stars · 68/120 Roast Me

GALECTIN THERAPEUTICS INC. Earnings Per Share, Basic and Diluted

GALECTIN THERAPEUTICS INC. (GALT) reported Earnings Per Share, Basic and Diluted of -$0.15 per share for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-16.

Discontinued › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-08-16

  • GALECTIN THERAPEUTICS INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.15.
  • GALECTIN THERAPEUTICS INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.11.
  • GALECTIN THERAPEUTICS INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.14.
  • GALECTIN THERAPEUTICS INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.10.
  • GALECTIN THERAPEUTICS INC. earnings per share, basic and diluted for fiscal 2020 was -$0.41.
  • GALECTIN THERAPEUTICS INC. earnings per share, basic and diluted for fiscal 2019 was -$0.39.
  • GALECTIN THERAPEUTICS INC. earnings per share, basic and diluted for fiscal 2018 was -$0.38.
  • GALECTIN THERAPEUTICS INC. earnings per share, basic and diluted for fiscal 2017 was -$0.49.
Period endEarnings Per Share, Basic and Diluted 3 monthEarnings Per Share, Basic and Diluted 3 month as first filedEarnings Per Share, Basic and Diluted 6 monthEarnings Per Share, Basic and Diluted 6 month as first filedEarnings Per Share, Basic and Diluted 9 monthEarnings Per Share, Basic and Diluted 9 month as first filedEarnings Per Share, Basic and Diluted 12 month
2021-06-30-$0.15
10-Q · filed 2021-08-16
-$0.26
10-Q · filed 2021-08-16
-$0.40
derived: net income ÷ weighted average shares · filed 2022-08-15
-$0.50
derived: net income ÷ weighted average shares · filed 2022-08-15
2021-03-31-$0.11
10-Q · filed 2021-05-17
-$0.25
derived: net income ÷ weighted average shares · filed 2022-05-16
-$0.35
derived: net income ÷ weighted average shares · filed 2022-05-16
-$0.46
derived: net income ÷ weighted average shares · filed 2022-05-16
2020-12-31-$0.14
derived: net income ÷ weighted average shares · filed 2022-03-31
-$0.24
derived: net income ÷ weighted average shares · filed 2022-03-31
-$0.35
derived: net income ÷ weighted average shares · filed 2022-03-31
-$0.41
10-K · filed 2021-03-31
2020-09-30-$0.10
10-Q · filed 2020-11-09
-$0.21
derived: net income ÷ weighted average shares · filed 2021-11-15
-$0.28
10-Q · filed 2020-11-09
-$0.39
derived: net income ÷ weighted average shares · filed 2021-11-15
2020-06-30-$0.11
10-Q · filed 2021-08-16
-$0.17
10-Q · filed 2021-08-16
-$0.29
derived: net income ÷ weighted average shares · filed 2021-08-16
-$0.33
derived: net income ÷ weighted average shares · filed 2021-08-16
2020-03-31-$0.06
10-Q · filed 2021-05-17
-$0.18
derived: net income ÷ weighted average shares · filed 2021-05-17
-$0.22
derived: net income ÷ weighted average shares · filed 2021-05-17
-$0.28
derived: net income ÷ weighted average shares · filed 2021-05-17
2019-12-31-$0.12
derived: net income ÷ weighted average shares · filed 2021-03-31
-$0.16
derived: net income ÷ weighted average shares · filed 2021-03-31
-$0.22
derived: net income ÷ weighted average shares · filed 2021-03-31
-$0.39
10-K · filed 2021-03-31
2019-09-30-$0.05
10-Q · filed 2020-11-09
$0.05
10-Q · filed 2019-11-12
-$0.11
derived: net income ÷ weighted average shares · filed 2020-11-09
-$0.27
10-Q · filed 2020-11-09
$0.27
10-Q · filed 2019-11-12
-$0.38
derived: net income ÷ weighted average shares · filed 2020-11-09
2019-06-30-$0.06
10-Q · filed 2020-08-10
$0.06
10-Q · filed 2019-08-09
-$0.26
10-Q · filed 2020-08-10
$0.26
10-Q · filed 2019-08-09
-$0.34
derived: net income ÷ weighted average shares · filed 2020-08-10
-$0.42
derived: net income ÷ weighted average shares · filed 2020-08-10
2019-03-31-$0.20
10-Q · filed 2020-05-11
$0.20
10-Q · filed 2019-05-10
-$0.29
derived: net income ÷ weighted average shares · filed 2020-05-11
-$0.37
derived: net income ÷ weighted average shares · filed 2020-05-11
-$0.47
derived: net income ÷ weighted average shares · filed 2020-05-11
2018-12-31-$0.08
derived: net income ÷ weighted average shares · filed 2020-03-16
-$0.16
derived: net income ÷ weighted average shares · filed 2020-03-16
-$0.26
derived: net income ÷ weighted average shares · filed 2020-03-16
-$0.38
10-K · filed 2020-03-16
2018-09-30$0.07
10-Q · filed 2019-11-12
-$0.07
10-Q · filed 2018-11-13
-$0.18
derived: net income ÷ weighted average shares · filed 2019-11-12
$0.30
10-Q · filed 2019-11-12
-$0.30
10-Q · filed 2018-11-13
-$0.37
derived: net income ÷ weighted average shares · filed 2019-11-12
2018-06-30$0.11
10-Q · filed 2019-08-09
-$0.11
10-Q · filed 2018-08-14
$0.23
10-Q · filed 2019-08-09
-$0.23
10-Q · filed 2018-08-14
-$0.30
derived: net income ÷ weighted average shares · filed 2019-08-09
-$0.43
derived: net income ÷ weighted average shares · filed 2019-08-09
2018-03-31$0.12
10-Q · filed 2019-05-10
-$0.12
10-Q · filed 2018-05-11
-$0.19
derived: net income ÷ weighted average shares · filed 2019-05-10
-$0.32
derived: net income ÷ weighted average shares · filed 2019-05-10
-$0.46
derived: net income ÷ weighted average shares · filed 2019-05-10
2017-12-31-$0.07
derived: net income ÷ weighted average shares · filed 2019-03-06
-$0.20
derived: net income ÷ weighted average shares · filed 2019-03-06
-$0.34
derived: net income ÷ weighted average shares · filed 2019-03-06
-$0.49
10-K · filed 2019-03-06
2017-09-30-$0.13
10-Q · filed 2018-11-13
-$0.27
derived: net income ÷ weighted average shares · filed 2018-11-13
-$0.42
10-Q · filed 2018-11-13
-$0.59
derived: net income ÷ weighted average shares · filed 2018-11-13
2017-06-30-$0.14
10-Q · filed 2018-08-14
-$0.29
10-Q · filed 2018-08-14
-$0.45
derived: net income ÷ weighted average shares · filed 2018-08-14
-$0.61
derived: net income ÷ weighted average shares · filed 2018-08-14
2017-03-31-$0.15
10-Q · filed 2018-05-11
-$0.32
derived: net income ÷ weighted average shares · filed 2018-05-11
-$0.48
derived: net income ÷ weighted average shares · filed 2018-05-11
-$0.67
derived: net income ÷ weighted average shares · filed 2018-05-11
2016-12-31-$0.16
derived: net income ÷ weighted average shares · filed 2018-03-29
-$0.32
derived: net income ÷ weighted average shares · filed 2018-03-29
-$0.52
derived: net income ÷ weighted average shares · filed 2018-03-29
-$0.76
10-K · filed 2018-03-29
2016-09-30-$0.16
10-Q · filed 2017-11-07
-$0.19
10-Q · filed 2016-11-08
-$0.36
derived: net income ÷ weighted average shares · filed 2017-11-07
-$0.60
10-Q · filed 2017-11-07
-$0.64
10-Q · filed 2016-11-08
-$0.79
derived: net income ÷ weighted average shares · filed 2017-11-07
2016-06-30-$0.20
10-Q · filed 2017-08-14
-$0.44
10-Q · filed 2017-08-14
-$0.64
derived: net income ÷ weighted average shares · filed 2017-08-14
-$0.89
derived: net income ÷ weighted average shares · filed 2017-08-14
2016-03-31-$0.24
10-Q · filed 2017-05-15
-$0.44
derived: net income ÷ weighted average shares · filed 2017-05-15
-$0.69
derived: net income ÷ weighted average shares · filed 2017-05-15
-$0.90
derived: net income ÷ weighted average shares · filed 2017-05-15
2015-12-31-$0.19
10-K · filed 2016-03-15
-$0.45
derived: net income ÷ weighted average shares · filed 2017-03-28
-$0.66
derived: net income ÷ weighted average shares · filed 2017-03-28
-$0.88
10-K · filed 2017-03-28
2015-09-30-$0.26
10-Q · filed 2016-11-08
-$0.47
derived: net income ÷ weighted average shares · filed 2016-11-08
-$0.69
10-Q · filed 2016-11-08
-$0.87
derived: net income ÷ weighted average shares · filed 2016-11-08
2015-06-30-$0.21
10-Q · filed 2016-08-09
-$0.43
10-Q · filed 2016-08-09
-$0.61
derived: net income ÷ weighted average shares · filed 2016-08-09
-$0.78
derived: net income ÷ weighted average shares · filed 2016-08-09
2015-03-31-$0.22
10-Q · filed 2016-05-10
-$0.40
derived: net income ÷ weighted average shares · filed 2016-05-10
-$0.57
derived: net income ÷ weighted average shares · filed 2016-05-10
-$0.74
derived: net income ÷ weighted average shares · filed 2016-05-10
2014-12-31-$0.17
10-K · filed 2016-03-15
-$0.35
derived: net income ÷ weighted average shares · filed 2016-03-15
-$0.52
derived: net income ÷ weighted average shares · filed 2016-03-15
-$0.78
10-K · filed 2016-03-15
2014-09-30-$0.17
10-K · filed 2016-03-15
-$0.34
derived: net income ÷ weighted average shares · filed 2016-03-15
-$0.60
10-Q · filed 2015-11-09
-$0.78
derived: net income ÷ weighted average shares · filed 2016-03-15
2014-06-30-$0.17
10-K · filed 2016-03-15
-$0.42
10-Q · filed 2015-08-10
-$0.61
derived: net income ÷ weighted average shares · filed 2016-03-15
-$0.83
derived: net income ÷ weighted average shares · filed 2016-03-15
2014-03-31-$0.27
10-K · filed 2016-03-15
-$0.44
derived: net income ÷ weighted average shares · filed 2016-03-15
-$0.66
derived: net income ÷ weighted average shares · filed 2016-03-15
-$1.33
derived: net income ÷ weighted average shares · filed 2016-03-15
2013-12-31-$0.14
10-K · filed 2015-03-18
-$0.39
derived: net income ÷ weighted average shares · filed 2016-03-15
-$1.08
derived: net income ÷ weighted average shares · filed 2016-03-15
-$1.30
10-K · filed 2016-03-15
2013-09-30-$0.22
10-K · filed 2015-03-18
-$0.92
derived: net income ÷ weighted average shares · filed 2015-03-18
-$1.15
10-Q · filed 2014-11-10
-$1.32
derived: net income ÷ weighted average shares · filed 2015-03-18
2013-06-30-$0.72
10-K · filed 2015-03-18
-$0.94
10-Q · filed 2014-08-07
-$1.11
derived: net income ÷ weighted average shares · filed 2015-03-18
-$1.30
derived: net income ÷ weighted average shares · filed 2015-03-18
2013-03-31-$0.22
10-K · filed 2015-03-18
-$0.39
derived: net income ÷ weighted average shares · filed 2015-03-18
-$0.57
derived: net income ÷ weighted average shares · filed 2015-03-18
-$0.76
derived: net income ÷ weighted average shares · filed 2015-03-18
2012-12-31-$0.17
derived: net income ÷ weighted average shares · filed 2015-03-18
-$0.36
derived: net income ÷ weighted average shares · filed 2015-03-18
-$0.55
derived: net income ÷ weighted average shares · filed 2015-03-18
-$0.72
10-K · filed 2015-03-18
2012-09-30-$0.19
10-Q · filed 2013-11-12
-$0.38
derived: net income ÷ weighted average shares · filed 2013-11-12
-$0.55
10-Q · filed 2013-11-12
-$0.83
derived: net income ÷ weighted average shares · filed 2013-11-12
2012-06-30-$0.19
10-Q · filed 2013-08-14
-$0.36
10-Q · filed 2013-08-14
-$0.64
derived: net income ÷ weighted average shares · filed 2013-08-14
-$0.83
derived: net income ÷ weighted average shares · filed 2013-08-14
2012-03-31-$0.17
10-Q · filed 2013-05-10
-$0.46
derived: net income ÷ weighted average shares · filed 2013-05-10
-$0.65
derived: net income ÷ weighted average shares · filed 2013-05-10
-$0.98
derived: net income ÷ weighted average shares · filed 2013-05-10
2011-12-31-$0.29
derived: net income ÷ weighted average shares · filed 2013-03-29
-$0.48
derived: net income ÷ weighted average shares · filed 2013-03-29
-$0.81
derived: net income ÷ weighted average shares · filed 2013-03-29
-$1.06
10-K · filed 2013-03-29
2011-09-30-$0.19
10-Q · filed 2012-11-09
-$0.03
10-Q · filed 2011-11-10
-$0.52
derived: net income ÷ weighted average shares · filed 2012-11-09
-$0.77
10-Q · filed 2012-11-09
-$0.13
10-Q · filed 2011-11-10
2011-06-30-$0.34
10-Q · filed 2012-08-10
-$0.06
10-Q · filed 2011-08-12
-$0.59
10-Q · filed 2012-08-10
-$0.10
10-Q · filed 2011-08-12
2011-03-31-$0.24
10-Q · filed 2012-05-11
2010-12-31-$0.93
10-K · filed 2012-03-30
2010-09-30-$0.03
10-Q · filed 2011-11-10
-$0.13
10-Q · filed 2011-11-10
2010-06-30-$0.05
10-Q · filed 2011-08-12
-$0.10
10-Q · filed 2011-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Rezolute, Inc. (RZLT)United States$0.382B-6.45
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63